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A B S T R A C T
Background: Differentiation of human embryonic stem cells (hESCs) into distinct neural lineages has been widely
studied. However, preparation of mixed yet neurochemically mature populations, for the study of neurological
diseases involving mixed cell types has received less attention.
New method: We combined two commonly used differentiation methods to provide robust and reproducible
cultures in which a mixture of primarily GABAergic and Glutamatergic neurons was obtained. Detailed char-
acterisation by immunocytochemistry (ICC) and quantitative real-time PCR (qPCR) assessed the neurochemical
phenotype, and the maturation state of these neurons.
Results: We found that once neurospheres (NSs) had attached to the culture plates, proliferation of neural stem
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cell was suppressed. Neuronal differentiation and synaptic development then occurred after 21 days in vitro
(DIV). By 49DIV, there were large numbers of neurochemically and structurally mature neurons. The qPCR
studies indicated that expression of GABAergic genes increased the most (93.3-fold increase), followed by
glutamatergic (51-fold increase), along with smaller changes in expression of cholinergic (3-fold increase) and
dopaminergic genes (6-fold increase), as well as a small change in glial cell marker expression (5-fold increase).
Comparison with existing method (s): Existing methods isolate hESC-derived neural progenitors for onward dif-
ferentiation to mature neurons using either migration or dissociative paradigms. These give poor survival or
yield. By combining these approaches, we obtain high yields of morphologically and neurochemically mature
neurons. These can be maintained in culture for extended periods.
Conclusion: Our method provides a novel, effective and robust neural culture system with structurally and
neurochemically mature cell populations and neural networks, suitable for studying a range of neurological
diseases from a human perspective.
1. Introduction
Studying the mechanisms of neurological diseases in vitro still lar-
gely relies on rodent models (Hazzouri et al., 2014) or immortalised
human cell lines (Alheim and Bartfai, 1998), which are unable to fully
recapitulate the pathophysiology of human diseases, a deficiency which
may contribute to translational failures in neuroscience (Landis et al.,
2012). Since the first human embryonic stem cell (hESC) lines were
derived from human blastocysts in 1998 (Thomson et al., 1998), their
potential for regenerative medicine and mechanistic studies soon be-
came recognised. The development of the first hESC-derived neural
lineage cells in 2001 (Carpenter et al., 2001; Reubinoff et al., 2001) has
proven extremely valuable for a wide range of studies on early human
neurogenesis, modelling of neurological diseases and screening of
neuro-pharmacological inventions. Importantly, the major neural cell
types generated in vitro have recapitulated the key features and func-
tions of the same cells in the adult brain (Dhara et al., 2008;
Prajumwongs et al., 2016; Shinde et al., 2016).
Previous studies have focused on single transmitter phenotypes,
such as the loss of dopaminergic neurons for modelling Parkinson’s
diseases (Datta et al., 2013) and the loss of GABAergic neurons for
modelling Huntington’s disease (Lee et al., 2009) or mixed population
of dopaminergic and motor neurons (Chambers et al., 2009). Other
studies have described maturation in terms of pan-neuronal markers
(Lappalainen et al., 2010a) or not described maturation at all (Axell
et al., 2009). In the case of most organoid cultures, the focus of the
studies has been on the specificity of cortical layering (Pasca et al.,
2015) rather than neurotransmitter phenotype. However, preparation
of mixed neuronal populations with molecularly defined neuro-
transmitter characteristics has been less well studied. We have char-
acterised the GABAergic, glutamatergic, cholinergic and dopaminergic
profiles of our cultures.
Mixed neurotransmitter populations are important for the study of
neurological diseases, which affect multiple cellular populations within
large volume of tissue damage caused by insults such as stroke, neo-
natal hypoxia, traumatic brain injury or epilepsy. They are also likely to
be important for the study of cell-cell interactions in these and other
neurological diseases.
In the present study, we report a novel method to generate hESC-
derived adherent cultures with structurally mature mixed neural po-
pulations in a simple and reproducible way. We also characterise the
neurochemical specificity and the structural morphology by im-
munocytochemistry (ICC) and quantitative real-time PCR (qPCR).
2. Material and Methods
2.1. Neural induction by noggin treatment and neurosphere (NS) formation
H9 (WA09) hESC line was originally acquired from WiCell Research
Institute, and regularly maintained in the Stem Cell Core Facility at the
Florey Institute, Australia. Mycoplasma contamination was routinely
tested. Initiation of neural specification was previously described
(Dottori and Pera, 2007). Before use, the hESC colonies were ranked
from 5 to 1. Colonies scoring 5 had the most ESC-like morphologically
while colonies scoring 1 contained lots of cells with differentiated
morphology (thicker, cyst-like with uneven surfaces). Only colonies
scoring 5-4 were used, and from within these colonies the most un-
differentiated areas (usually between the middle of the colony and the
edge, presenting with a clean edge and tightly packed cells) were se-
lected. In brief, undifferentiated portions of hESC colonies were me-
chanically cut into small pieces of approximately equal size, and plated
onto mitotically inactivated mouse embryonic fibroblasts (MEFs) in hES
Fig. 1. Schematic timeline of human embryonic stem cells (hESCs) undergoing neural induction by noggin and differentiation over 49 days in vitro (DIV).
hESCs were treated with noggin to induce neurosphere (NS) formation. After 14 days expansion, the 14-day NSs were plated down for 28 days, followed by another
21-day culture after dissociation to acquire 49DIV neurons.
Y. Liu et al. Journal of Neuroscience Methods 308 (2018) 286–293
287
medium (Supplementary material, Table 1) containing 500 ng/mL
noggin (R&D systems, 6057-NG-100). The cells were cultured at 37◦C
in 5% CO2 with 95% humidity for 14 days without passaging, and the
medium was changed every other day. For the 0-day Noggin treated
colonies, the colonies were full of rosettes, which were a sign of suc-
cessful neural induction. To generate neurospheres (NSs), noggin
treated colonies were cut using the tip of a 26-gauge needle on a grid so
that the size of each sphere (approximately 500 x 500 μm) was much
better controlled, and transferred to individual wells in a low adherent
96-well plate (Sigma Aldrich, CLS7007-24EA) containing Neurobasal
Medium (NBM, components listed in Supplementary material, Table 2)
supplemented with epidermal growth factor (EGF, Invitrogen,
PHG0314, 20 ng/mL) and fibroblast growth factor (bFGF, Invitrogen,
13256029, 20 ng/mL). NSs were cultured in suspension for 14 days
with the medium changed every second day (Fig. 1).
2.2. Differentiation and culture of hESC-derived neural cells for long term
Fourteen-day NSs were cut into smaller pieces under a dissection
microscope (LEICA, IC80 HD) using the tip of a 26-gauge needle. Four
to five pieces with similar size were placed into individual wells in a 24-
well plate pre-coated with poly-d-lysine (PDL) and laminin (10 μg/mL,
Sigma, P6407, Life Tech, 23017015). NS pieces were cultured in NBM
without EGF and bFGF for 28 days and NBM was changed every two
Fig. 2. Adhesion phases (A, B, C): 14-day NSs differentiated for 14DIV in phase contrast picture (A), or 28DIV with staining of Nestin and MAP2 at 28DIV (B).
Quantitative immunocytochemistry (ICC) fluorescence measures of Nestin and MAP2 expression at 7, 14 and 21DIV (C). Dissociation phases (D-L): ICC staining
with NeuN and MAP2 (D-F), and with βIII-tubulin and Synapsin1 (G-I) at 39, 42 and 50DIV. Staining with S100β and MAP2 at 49DIV (J). Staining with NeuN and Tau
at 49DIV (K). Quantitative fluorescence measures of Nestin, MAP2 at 39, 42 and 50DIV and NeuN expression at 42 and 50DIV (L). Data is presented as mean ± SEM.
Statistical significances are detected at **p < 0.01, ***p < 0.0001 by one way-ANOVA with Bonferroni post-test comparing all columns across different time
points.
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days. Cell samples were collected on days 7, 9, 14 and 21 for sub-
sequent analysis.
At 28 days, adherent cell cultures were treated with accutase
(Thermo Fisher, A1110501, supplied as ready-to-use cell dissociation
reagent) and incubated for 5minutes at 37 °C to allow adherent cells to
detach. Cell clumps were then collected and mechanically broken down
by passing through a P1000 Gilson pipette until a homogenised cell
suspension was achieved. Accutase was removed by dilution in an equal
volume of NBM followed by centrifuged at 300 g for 4minutes at room
temperature. Cell pellets were then re-suspended in NBM, filtered
through 40 μm cell strainers (BD, 352340), and plated onto PDL and
laminin coated 35mm2 dishes or coverslips (No 1, 13mm round Menzel
PK100, Grale Scientific, CS13100) at a density of 700,000 cells/dish.
The cells were then incubated at 37 °C in 5% CO2 with 95% humidity,
and NBM was changed every second day until experiments terminated
on days 39, 42, 49 and 50 (Fig. 1).
2.3. RNA extraction and quantitative real-time PCR (qPCR)
RNA was extracted for analysis from 14-day NSs and differentiated
neural cells were harvested at 9, 14, 21 and 49 DIV. RNA extraction was
performed using RNeasy Plus MINI Kits (Qiagen, cat. 74104) with DNA-
free treatment (Qiagen, RNase-free DNase Set, 79254) following man-
ufacturer’s instructions. NanoDrop 2000 spectrophotometry (Thermo
Fisher, ND-2000) was used to quantify the concentration and the purity
of all samples. Only samples with an A260/A280 ratio between 1.9-2.1
were used. cDNA was synthesized following the recommended proto-
cols from the SuperScript III First-Strand Synthesis SuperMix kit
(Invitrogen; Cat. No: 18080-400) with RNA amount adjusted to 75 ng
per cDNA reaction. Neural differentiation markers (SOX2, PAX6, MAP2,
NESTIN, GAP43, SYN1, S100B, GFAP, OLIG2) were amplified using
either in house-designed gene-specific primers or TaqMan primers
(Supplementary material, Table 3). All qPCR reactions were performed
in triplicates using an ABI 7900-HT system (Applied Biosystems) with
no reverse transcriptase and primer controls included in each assay run.
For all qPCR reactions, at least three independent experiments were
conducted for each marker.
2.4. Immunocytochemistry (ICC)
Differentiated neural cells were fixed in 4% paraformaldehyde
(PFA), and blocked in 10% foetal calf serum (FCS) before incubation
with the appropriate concentration of primary antibodies
(Supplementary material, Table 4) diluted in 3% FCS, and 0.3% Triton-
x at 4 °C overnight. Secondary antibodies (Supplementary material,
Table 5) were applied at a dilution of 1:500 (PBS containing 2% FCS)
for 60minutes at room temperature in the dark. A 1mg/mL 4',6-dia-
midino-2-phenylindole (DAPI, Life Tech, 62248) stock solution was
diluted in PBS (1:10, 000) before adding to the wells to stain for the
nucleus. After 10minutes, the DAPI solution was washed off twice with
PBS before mounting the coverslips on glass slides with the anti-fade
reagent (Molecular probes, P36930). The cells were visualised at 20x
magnification using a Zeiss inverted fluorescence Microscope (Axio
Observer 7).
2.5. MitoTracker staining
To stain mitochondria, the cell-permeant MitoTracker probe
(ThermoFisher, M7512) was added to live cells in Neurobasal Medium
at a concentration of 80 nM, and incubated for 30minutes at 37 °C.
Fig. 3. Gene expression of pluripotency markers (A, B), synaptic markers (C) and glial markers (D) at different time points during hESC differentiation.
Statistical significances are detected at *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA. *, as compared to 14-day NS, #, as compared to the previous
time points.
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Fig. 4. Gene expression of glutamatergic neuronal markers (A, B), GABAergic neuronal markers (C) and other transmitter markers (D) at different time
points during hESC differentiation. 14-day NSs differentiated for 49DIV, and stained for NR1 and MAP2 (E), PSD-95 and MAP2 (F), VGluT1 and
MitoTracker (G) and GAD67 and MAP2 (H). Statistical significances are detected at *p < 0.05, **p < 0.01, ***p < 0.001 by One-way ANOVA. *, as compared to
14-day NS, #, as compared to the previous time points.
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After three washes with PBS, the cells were fixed by immersion in 4%
PFA before visualisation or further proceeding for ICC (see above).
2.6. Statistical analysis
Gene expression data (average of three replications) were acquired
from ViiA7 Real-Time PCR system (ABI 7900-HT system), and relative
fold change values were calculated using the ΔΔCt quantitation method
(Schmittgen and Livak, 2008). GAPDH and ELF1 were used for nor-
malisation and calibration of gene expression for each sample. All the
fold changes were normalised to 14-day NS gene expression data. For
immunocytochemistry, the total number of DAPI-positive nuclei and of
immuno-positive cells was determined by manual counting using the
standard features of Image J software (version 1.50i; NIH, Bethesda).
Each result depicted summarises the data from three independent
experiments, each with multiple technical replicates (a minimum of
two).
One-way analysis of variance (ANOVA) with Bonferroni post-hoc
error correction was used to identify significant differences in gene and
protein expression between time points. Data are presented as
mean ± SEM. Statistical significance is detected at p≤ 0.05. At least
three independent biological repeats were performed for each experi-
ment.
3. Results
3.1. Neuronal maturation during hESC neural differentiation
When NS pieces were cultured (usually multiple pieces per well)
(Fig. 2A, neurosphere piece 1/NS1, neurosphere piece2/NS2), they
grew rapidly and sent out profuse neurites. As time in culture increased,
the neurite mesh became more complex, often including what appeared
to be large bundles of fibres between NSs (Fig. 2A, white arrows).
During this period, expression of the neural stem cell marker Nestin
showed a downward trend along with increasing differentiation, de-
creasing from 76.22 ± 7.77% at 7DIV to 55.11 ± 10.85% at 28DIV
(Fig. 2B, C). By contrast, expression of the early neuronal marker MAP2
increased steadily from 42.33 ± 6.23% at 7DIV to 61.95 ± 5.16% at
28DIV (Fig. 2B, C). On average the 14d neurospheres had an area of
0.44 ± 0.1 mm2 (mean ± sem). For each experiment, all of the
available neurospheres were pooled and dissociated, minimising the
risk that an individual neurosphere with aberrant size or differentiation
would unduly influence downstream culture.
Following dissociation, the number of Nestin positive cells declined
further to around 10% of the total cell number and remained at this
level until 50DIV. In contrast, MAP2 expression significantly increased
from 33.34 ± 3.12% at 39DIV to 50.3 ± 2.52% (p < 0.01) at 42DIV
and 80%±4.04% (p < 0.001) at 49DIV (Fig. 2L). Moreover, nearly
80% of the MAP2 positive cells present at 50DIV co-expressed the
mature neuronal marker NeuN (Fig. 2F, L).
The synaptic marker Synapsin-1 was extensively co-expressed with
βIII-tubulin in neuronal processes, and showed increased expression
from 39DIV to 50DIV (Fig. 2G, H, I). At 49DIV, the cytoskeleton protein
Tau was widely distributed both inside the cytoplasm and in neuronal
processes. Additionally, the majority of Tau stained cells were also
NeuN positive (Fig. 2K).
3.2. Characterization of neural cell lineage by ICC and qPCR
We next measured the mRNA levels for the early neural stem cell
markers, neuronal and glial progenitor markers as well as markers of
neurochemically mature neurons.
Expression of SOX2, a marker of neural stem cell/progenitor re-
newal, did not change significantly after the initiation of differentia-
tion. Expression of PAX6, a transcription factor controlling regional
patterning did not change significantly, although expression appeared
slightly greater at 9DIV, 14DIV and 21DIV (Fig. 3A). Expression of
NESTIN, a marker of commitment to a neural lineage, remained un-
changed as more specialised differentiation continued. Conversely,
expression of MAP2, a marker of neurite outgrowth increased sig-
nificantly between 21 and 49DIV (7.5 ± 0.93 fold, p < 0.001)
(Fig. 3B).
We also assessed expression of the synaptogenic markers GAP43 and
SYN1. A trend towards increased expression of the growth cone marker
GAP43 was seen after 21DIV and was then maintained to 49DIV
(2.5 ± 0.75 fold). Expression of SYN1 became evident after 21DIV
(5 ± 0.51 fold, p < 0.01), and steadily increased until 49DIV
(10 ± 1.36 fold, p < 0.001) (Fig. 3C).
Even though neurons represented the most abundant cell type, we
also identified a small population of glial cells. Expression of the as-
trocytic marker S100B was detectable by 9DIV and reached 5.6 ± 3.5
fold at 49DIV. Expression of GFAP was detected later (21DIV), but
showed a similar fold change by 49DIV (4.37 ± 0.86 fold, p < 0.001)
(Fig. 3D). Immunocytochemistry confirmed the presence of small
numbers of morphologically unusual S100β positive glial progenitors
with small cell bodies, and long processes amongst the growing neu-
ronal populations (Fig. 2J). The oligodendrocyte progenitor marker
OLIG2, also did not change significantly during the experiment, but
appeared to show a small burst of expression at 14DIV and 21DIV
(Fig. 3D).
3.3. Characterization of neurochemical and morphological phenotypes by
ICC and qPCR
The metabotropic glutamate receptors (subtype 2-GRM2 and sub-
type 5-GRM5), which are activated through second messenger path-
ways, showed a significant increase in expression during the differ-
entiation. Expression of GRM5 gradually increased from the 14-day NS
stage, and reached a peak expression of 41.37 ± 6 fold at 49DIV
(p < 0.001). Expression of GRM2 plateaued briefly at 14DIV
(24.4 ± 2.7 fold) before continuing to increase to 74.25 ± 19 fold at
49DIV (p < 0.01) (Fig. 4A).
NMDA receptor 1 (NR1) plays a critical role in regulating Ca2+
influx during glutamatergic transmission through ionotropic channels.
Expression of NR1 increased from 14DIV to 21DIV (31.83 ± 4 fold,
p < 0.01), and continued to rise until 49DIV (39 ± 5.87 fold,
p < 0.001). Expression of DLG4, encoding the protein postsynaptic
density 95 (PSD-95), which is an essential component in regulating
glutamate release and re-uptake during the interaction with NMDA
receptors, increased less dramatically, rising only 3.8 ± 1.1 fold
(p < 0.01) at 49DIV (Fig. 4B).
Expression of markers for inhibitory GABAergic neurons, on the
other hand, showed a much later maturation but greater fold changes.
Neurons in our culture expressed genes for two of the most important
GABA synthetic enzymes, namely GAD67 (encoded by GAD1) and
GAD65 (encoded by GAD2). Their expression increased 70 ± 19 fold
(p < 0.01) and 99 ± 12 fold (p < 0.001), respectively, at 49DIV
while the GABA receptor1 (GABBR1) increased 111 ± 51 fold
(p < 0.05) by 49DIV (Fig. 4C).
We also detected two enzymes involved in cholinergic neuro-
transmission, CHAT and ACHE, however with much lower increases in
expression as compared to the GABAergic or glutamatergic markers.
Expression of CHAT showed a small increase of expression at 14DIV
(2.12 ± 0.37 fold, p < 0.05) and 21DIV (1.77 ± 0.15, p < 0.05)
before declining by 49DIV. Expression of ACHE peaked by 21DIV and
remained elevated at 49DIV (3.87 ± 0.72 fold, p < 0.01). Expression
of TH, an enzyme required for dopaminergic synthesis, showed elevated
expression at 21DIV (2.3 ± 0.39 fold, p < 0.01), and continued to rise
until 49DIV (6.2 ± 0.6 fold, p < 0.001) (Fig. 4D).
ICC staining confirmed the gene expression data showing that
staining of NR1 was largely confined to cell bodies, often with typical
pyramidal morphologies (Fig. 4E, white arrow). PSD-95 staining was
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punctate with nodes distributed along dendrites stained with MAP2
(Fig. 4F, white arrow). VGluT1, which transports glutamate from the
cytoplasm to synaptic vesicles, stained strongly in the cytoplasm of
many 49DIV neurons (Fig. 4G, white arrow). Staining of GAD67 was
extensively expressed in our 49DIV culture, and associated with both
the cell body and processes (Fig. 4H, white arrow).
4. Discussion
In this study, we describe the establishment of a novel, long-term
culture method that was developed by adapting two of the more com-
monly described differentiation methods, the classic NS attachment
(Dottori and Pera, 2007) and the dissociation methods (Zhang and
Zhang, 2010). This new culture method allows for a long-term (over 7
weeks) culture of healthy neurochemically and structurally mature
neurons.
We postulated that performing dissociation when the NSs were 28
days old would minimise damage to the early progenitors, which are
reported to still need strong cell-cell contact for survival (Svendsen
et al., 1998). During the adhesion phase of our combined method,
neural progenitors within the NSs and those that migrated out of the
NSs were allowed to further proliferate, rather than push towards dif-
ferentiation. Thus, at 28DIV of the adhesion phase, approximately 50%
of the cells in the un-dissociated culture retained an immature neural
progenitor phenotype (Fig. 2B, C). After dissociation at 28DIV, the cells
recovered for approximately 7 days and by 39DIV, the Nestin positive
progenitor phenotype had nearly disappeared (10%, Fig. 2L). By con-
trast, a more mature MAP2 and NeuN positive population emerged
(Fig. 2, D, G, L), and this continued until complex structure in cultures
had evolved at 50DIV (Fig. 2, F, I, L). By dissociating cells half way
through the “classic” period of NS culture, the benefits of continued
progenitor amplification and slow differentiation have been captured
before the detachment and death take place. These cells respond better
to dissociation than if this occurs very early in the NS growth (14-day
NSs) stage, and thus are able to grow and differentiate successfully. This
model does not have the problem of cell detachment, and we were able
to maintain cultures in good health for at least 21 further days after
dissociation, and successfully established consistently uniform cultures
of neurons that are amenable to morphological characterisation.
Culture of small NS clusters for longer than 7 weeks was reported in
only a few studies (Itsykson et al., 2005; Yla-Outinen et al., 2014;
Lappalainen et al., 2010b), however, these studies lacked detailed cell
lineage analysis, especially the neuronal transmitter characterisation as
described here. For examples, Itsykson et al only reported the expres-
sion of βIII-tubulin as the marker for neurons while Lappalainen et al
utilized βIII-tubulin and MAP2 as the markers for neurons. More im-
portantly, most of the current studies adopted the method of seeding
whole NSs in the culture, which created a very heterogeneous cell
distribution that was difficult to analyse (Itsykson et al., 2005; Erceg
et al., 2008).
After the neural culture was established, we performed detailed
characterisation to be able to understand the temporal profile of the
neural differentiation in our culture system. We found that expression
of the stem cell markers NESTIN, SOX2 and PAX6 did not change sig-
nificantly during the experiments (Fig. 3A, B). This suggests that once
the NSs were plated down, they shifted from stem cell proliferation to
neural progenitor proliferation and differentiation, consistent with the
morphological maturation with extensive axon and dendrite sprouting.
Our results also suggest that active axonal outgrowth began at 9DIV
as indicated by the expression of the growth cone marker GAP43
(Fig. 3C). Expression of the synaptic protein Synapsin-1 steadily in-
creased in expression every 7 days (Fig. 3C). By 49DIV, gene expression
of Synapsin-1 reached its maximum, and ICC revealed extensive posi-
tive punctate structures believed to be synapses (Fig. 2I). These findings
indicate a high level of neuronal maturation.
Since electrophysiology was not available for this experiment, to
better understand the neurochemical phenotype of our cultures, we
assessed the level of expression and distribution of a range of different
neuron transmitters by qPCR and ICC.
Gene expression of two glutamatergic receptors, ionotropic (NR1)
and metabotropic (mGluR2, mGluR5) was upregulated markedly once
the differentiation was initiated, and surged to 39, 74, and 41-fold,
respectively at 49DIV compared to 14-day NSs. ICC for NR1 showed
wide spread distribution of NMDA receptors in the 49DIV neurons
possessing typical pyramidal morphologies (Fig. 4E). This is important
because range of studies suggest that 70-80% of the total neurons in the
cortex are pyramidal glutamatergic neurons (as reviewed in Markram
et al., 2004).
Conversely, we did not see as dramatic a change in expression of
DLG4, the gene for PSD-95. However, this essential component of ex-
citatory neurotransmission was readily detected in punctate structures
along the MAP2 positive processes (Fig. 4F) by ICC at 49DIV. VGluT1
also had extensive expression in 49DIV neurons, with the protein de-
tected not only in the pyramidal neurons cell bodies, but also along
their processes, consistent with the previous study reporting increasing
VGluT1 expression in glutamatergic neuron synapses that are en-
sheathed by processes from individual developing astroglia in vivo
(Morel et al., 2014). These results indicate rapid maturation of two
major glutamate receptor types in large numbers of glutamatergic
neurons in our cultures.
GABA synthesis requires the activation of glutamate decarboxylase
genes (GAD1 and GAD2), which in our cultures showed a 30-fold in-
crease at 21DIV, and a 99- and 70-fold increase at 49DIV, respectively.
GABBR1, which is mainly located post-synaptically, had an even higher
expression of 111-fold compared to 14-day NSs. The GABAergic neu-
rons showed various morphologies, appearing as both pyramidal and
bipolar, which were consistent with similar features previously found in
cortical interneuron populations (Markram et al., 2004).
Conversely, we found that expression of the cholinergic genes for
ChAT and ACHE only increased 2-fold and 4-fold, respectively at
49DIV. This suggests that our culture method does not lead to a po-
pulation of neurons typical of cortical layers II-III where small bipolar
cholinergic neurons predominately reside (von Engelhardt et al., 2007).
Similarly, under spontaneous neural induction conditions in our
cultures, expression of TH only showed a 6-fold increase at 49DIV,
suggesting that the cultures lack signals like fibroblast growth factor 8
(FGF8) and sonic hedgehog (SHH) required to stimulate differentiation
of forebrain dopaminergic neuronal populations (Hynes and Rosenthal,
1999).
We also detected only low levels of glial marker expression for as-
trocytes and oligodendroglial progenitors. This makes these cultures
suitable for the study of the influence of adding these cells in different
proportions and times during the culture maturation.
This is the first description of generation of a neural population with
mixed forebrain neurotransmitter characteristics. In the future, the
addition of supplementary patterning factors could be used to further
enriched the cultures for specific neuronal types.
The limitation of our study is lacking electrophysiological char-
acterisation. However, other have shown that expression of the pan-
neuronal markers β-III tubulin usually appears at the same stage as the
ability to generate action potentials while the expression of specific
neuronal marker such as GAD1 is associated with spontaneous electrical
activity (Belinsky et al., 2014). Another limitation of our methods is
that the current manual cutting method limits scalability for high-
through-put studies.
Taken together, we have established a simple and reproducible
method to generate structurally mature neuronal populations from
hESCs. The molecular markers of neurochemical specificity (synthetic
enzymes), structural maturity (axons, synapses, post-synaptic densities)
and functional maturity (neurotransmitter receptors and transporters)
show increased expression after 21DIV and have increased further by
49DIV. ICC confirms that proteins such as NR1, PSD-95, VGluT1 and
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GAD1 which are required to sub-serve electrical activity are also pre-
sent at 49DIV.
5. Conclusion
We have described a new in vitro method for the generation of
clinically relevant human neurons from hESCs. These neurons are
morphologically and neurochemically mature. We believe these cul-
tures will provide a useful tool for the study of human neurological
diseases and drugs used to treat them.
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